A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Borregaard ASA engages in the development, production, and marketing of specialized biochemicals and biomaterials in Norway, rest of Europe, Asia, the United States, and internationally. It operates in three segments: BioSolutions, BioMaterials, and Fine Chemicals. The BioSolutions segment develops, produces, and sells biopolymers and biovanillin derived from lignin for agrochemicals, batteries, industrial binders, and construction, as well as to flavor and fragrance companies, and food and beverage industry. Its BioMaterials segment develops, produces, and sells speciality cellulose used as a raw material in the production of cellulose ethers, cellulose acetate, and other specialty products, as well as cellulose fibrils for industrial applications. The Fine Chemicals segment supplies fine chemical intermediates for contrast agents and advanced bioethanol. The company was incorporated in 2012 and is headquartered in Sarpsborg, Norway.
Financial Summary
| Share Statistics | BRGAY | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $1,536.1 | $3,315.4 | 52% |
|
| Shares Out (Mil) | 10.4 | 84.9 | 21% |
|
| Institutional Ownership | 49.5% | 78.8% | 23% |
|
| Float (Mil) | 99.3 | 121.7 | 60% |
|
| Beta | 0.61 | 0.82 | 34% |
|
| Avg Daily Volume (000s) | 1 | 145 | 4% |
|
| Price Change (52-week) |
na | 71.1% | na |
|
| Growth | BRGAY | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 4.2% | 3.7% | 33% |
|
| Net Income (5yr) | 3.9% | (0.3%) | 46% |
|
| EPS (5yr) | 3.9% | 1.7% | 37 |
|
| Dividends (5yr) | 10.1% | 0.0% | 69% |
|
| Cash Flow (5yr) | (23.4%) | (16.3%) | 28% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | BRGAY | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $818 | $3,655 | 47% |
|
| Net Income (TTM) (Mil) | $28 | $86 | 50% |
|
| EPS (TTM) | $0.281 | $0.600 | 48% |
|
| Operating Cash Flow (TTM) (Mil) | $171 | $372 | 57% |
|
| Net Cash Flow (TTM) (Mil) | $24 | $4 | 64% |
|
| Long-Term Debt (Q1) (Mil) | $171 | $1,378 | 48% |
|
| Enterprise Value (Q1) (Mil) | $1,812 | $5,246 | 48% |
|
| Valuation | BRGAY | Industry Median |
Percentile (All Stocks) |
|
| P/B | na | 1.36 | na |
|
| P/E | na | 21.9 | na |
|
| Dividend Yield | na | 1.2% | na |
|
| PEG (5yr hist) | na | 1.3 | na |
|
| Ratios | BRGAY | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 64.8% | 29.1% | 77% |
|
| Net Margin | 3.4% | 4.2% | 41% |
|
| ROA | 2.8% | 3.0% | 59% |
|
| ROE | 4.6% | 6.5% | 42% |
|
| Liabilities to Assets | 39.1% | 53.2% | 30% |
|
| F-Score | na | 5 | na |
|
Borregaard ASA did not pass any screens on 11/20/2026.